Thymic stromal lymphopoietin is a key mediator of breast cancer progression.
Olkhanud PB, Rochman Y, Bodogai M, Malchinkhuu E, Wejksza K, Xu M, Gress RE, Hesdorffer C, Leonard WJ, Biragyn A.
Olkhanud PB, et al. Among authors: bodogai m.
J Immunol. 2011 May 15;186(10):5656-62. doi: 10.4049/jimmunol.1100463. Epub 2011 Apr 13.
J Immunol. 2011.
PMID: 21490155
Free PMC article.